Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Right vs. Left Transradial Access for Coronary Procedures

Courtesy of Dr. Guillermo Migliaro.

Right vs. Left Transradial Access for Coronary ProceduresCoronary angiography and angioplasty via transradial approach are associated with a significant reduction in access site complications, compared with transfemoral and transbrachial access. Moreover, a significant reduction in mortality has been reported for procedures performed via transradial approach vs. transfemoral approach in primary angioplasty.

 

There is a limited number of studies comparing right and left transradial access. While right transradial access (RTA) is the preferred choice for most operators, it presents difficulties, mostly due to tortuosities in the subclavian artery, and reports suggest a higher incidence of stroke for this approach.

 

Left transradial access (LTA) does present a more direct pathway and is more similar to the transfemoral approach as regards catheterization, but is less convenient due to yuxtaposition at the abdomen.

 

This meta-analysis includes 12 randomized studies (5 diagnostic studies, and 7 therapeutic studies) comparing RTA and LTA in 6450 patients. There were no differences between groups regarding mean age and percentage of male patients.

 

Results

  • The rates for failure or crossover were similar for both strategies: 4.2% for right transradial access and 4.1% for left transradial access (p = 0.68).

 

  • The rates for procedure times were similar for both groups, 18.8 ± 10.3 min vs. 18.1 ± 10 min (p = 0.16).

 

  • Right transradial access presented longer fluoroscopy time, 5.8 ± 4.4 min vs. 5.3 ± 4.2 min (p <0.001), and greater contrast use, 84 ± 35 mL vs. 82 ± 34 mL (p = 0.003), when compared with left transradial access. 

 

  • A subgroup analysis showed that these significant differences were present only in diagnostic studies, but not when therapeutic and diagnostic studies were analyzed jointly.

 

  • There were no significant differences between both strategies regarding complications (0.6% for both groups) and the incidence of stroke (0.2% vs. 0.1%). There was a higher incidence of subclavian artery tortuosity in the right side (12% vs. 5%, p <0.0001).

 

Authors conclude that left transradial access is as safe and effective as right transradial access for both diagnostic and therapeutic procedures, with a small difference in fluoroscopy time and contrast use (for diagnostic procedures) in favor of the left radial approach.

 

Editorial

So far, this is the first comparative meta-analysis published comparing both strategies. This study does not report operator experience regarding access sites, which means that bias in this sense cannot be ruled out (some studies favor left transradial access for novice or training operators). The clinical relevance of the increase in fluoroscopy time for both patient and operator, and the relevance of the increase in contrast use for patients are still unclear.

 

Courtesy of Dr. Guillermo Migliaro. Buenos Aires German Hospital, Argentina.

 

Original title: Comparison of Transradial Coronary Procedures Via Right Versus Left Radial Artery Approach: A Meta Analysis.

Reference: Shah R et al. Catheter and Cardiovascular Interventions 2016;88:1027-1033.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...